148 related articles for article (PubMed ID: 38808109)
41. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.
Zhang J; Wang C; Tang Y; Peng H; Ye ZC; Li CC; Lou TQ
Nephrology (Carlton); 2013 Feb; 18(2):125-31. PubMed ID: 23134230
[TBL] [Abstract][Full Text] [Related]
42. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
43. Time-averaged albumin predicts the long-term prognosis of IgA nephropathy patients who achieved remission.
Ni Z; Yuan Y; Wang Q; Cao L; Che X; Zhang M; Xie Y; Qi C; Mou S
J Transl Med; 2014 Jul; 12():194. PubMed ID: 25011573
[TBL] [Abstract][Full Text] [Related]
44. Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome.
Han X; Xiao Y; Tang Y; Zheng X; Anwar M; Qin W
Clin Exp Med; 2019 Nov; 19(4):479-486. PubMed ID: 31542837
[TBL] [Abstract][Full Text] [Related]
45. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy.
Wu C; Wang AY; Li G; Wang L
BMC Nephrol; 2018 Dec; 19(1):381. PubMed ID: 30594167
[TBL] [Abstract][Full Text] [Related]
46. Cigarette smoking may accelerate the progression of IgA nephropathy.
Wang S; Qin A; Pei G; Jiang Z; Dong L; Tan J; Tan L; Tang Y; Qin W
BMC Nephrol; 2021 Jun; 22(1):239. PubMed ID: 34187402
[TBL] [Abstract][Full Text] [Related]
47. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.
Duan ZY; Bu R; Liang S; Chen XZ; Zhang C; Zhang QY; Li JJ; Chen XM; Cai GY
Front Immunol; 2024; 15():1326026. PubMed ID: 38426107
[TBL] [Abstract][Full Text] [Related]
48. Association of URG11 and Twist with clinical pathological characteristics and prognosis in patients with IgA nephropathy.
Du R; Zhao L; Xia L; Liu L; Sun W; Zhao A; Yu Y; Han H; Sun S
Nephrol Dial Transplant; 2013 Sep; 28(9):2268-76. PubMed ID: 23828164
[TBL] [Abstract][Full Text] [Related]
49. Roles of mesangial C3 and C1q deposition in the clinical manifestations and prognosis of IgAN.
Wang S; Dong L; Qin A; Tan J; Zhou X; Qin W
Int Immunopharmacol; 2023 Jul; 120():110354. PubMed ID: 37235963
[TBL] [Abstract][Full Text] [Related]
50. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871
[TBL] [Abstract][Full Text] [Related]
51. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R
Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002
[TBL] [Abstract][Full Text] [Related]
52. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
[TBL] [Abstract][Full Text] [Related]
53. [Retrospective Analysis of the Effect of Uric Acid on the Prognosis of Immunoglobulin A Nephropathy With Stage 3-4 Chronic Kidney Disease].
Yu Z; Qin Y; Yuan J; Zhao J; Sun S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1121-1127. PubMed ID: 38162075
[TBL] [Abstract][Full Text] [Related]
54. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969
[TBL] [Abstract][Full Text] [Related]
55. Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy.
Russo E; Drovandi S; Salvidio G; Verzola D; Esposito P; Garibotto G; Viazzi F
Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2343-2350. PubMed ID: 32912790
[TBL] [Abstract][Full Text] [Related]
56. Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology.
Lin Z; Liu L; Zhang R; Lin X; Lu F; Bao K; Wang L; Lin Q; Mai J; Cao Y; Yang H; Liu X; Zou C
Am J Nephrol; 2021; 52(6):507-518. PubMed ID: 34134110
[TBL] [Abstract][Full Text] [Related]
57. Renal expression of intercellular adhesion molecule-1 in immunoglobulin A nephropathy: tubulointerstitial injury and prognosis.
Arrizabalaga P; Solé M; Abellana R; Ascaso C; Cardesa A
Virchows Arch; 2001 Jul; 439(1):27-34. PubMed ID: 11499837
[TBL] [Abstract][Full Text] [Related]
58. Severity of nephrotic IgA nephropathy according to the Oxford classification.
Moriyama T; Nakayama K; Iwasaki C; Ochi A; Tsuruta Y; Itabashi M; Tsukada M; Takei T; Uchida K; Nitta K
Int Urol Nephrol; 2012 Aug; 44(4):1177-84. PubMed ID: 22231129
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
Liu S; Lu Z; Fu Z; Li H; Gui C; Deng Y
Kidney Blood Press Res; 2023; 48(1):186-193. PubMed ID: 37062274
[TBL] [Abstract][Full Text] [Related]
60. Clinical Significance of Crescent Formation in IgA Nephropathy - a Multicenter Validation Study.
Park S; Baek CH; Park SK; Kang HG; Hyun HS; Park E; Han SH; Ryu DR; Kim DK; Oh KH; Joo KW; Kim YS; Moon KC; Chin HJ; Lee H
Kidney Blood Press Res; 2019; 44(1):22-32. PubMed ID: 30808840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
